WHOOP, Field Trip partner to study impact of psychedelic therapies
Category: #health  By Nikita Chaurasia  Date: 2020-11-21
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

WHOOP, Field Trip partner to study impact of psychedelic therapies

WHOOP Inc., a prominent provider of health tracking and monitoring services, has reportedly announced a partnership with Field Trip Health Ltd., leader in development and delivery of psychedelic therapies. According to reliable sources, Field Trip will use WHOOP’s Strap 3.0 in order to determine biometric effects of its psychedelic therapies on mental and physiology health.

Field Trip reportedly intends to perform an observational study to understand if its ketamine-assisted therapies, which have been proved to be beneficial in treating mental health conditions including PTSD, anxiety, and depression, could improve physical health as well.

It is to be noted that, Field Trip has acquired WHOOP products and has gained access to additional data insights through a research collaboration and enterprise program. The firm is also planning to open Field Trip Health centers across Europe and North America for delivering their psychedelic therapies.

Dr. Ryan Yermus, Chief Clinical Officer at Field Trip, mentioned in a comment that clinical outcomes from their first three centers in Los Angeles, New York, and Toronto, have been overwhelmingly positive, with a substantial decrease in depressive symptoms, trauma-related symptoms, and anxiety.

If reports are to be believed, the research will initially be conducted on military veterans seeking ketamine-assisted therapies via Basecamp program of Field Trip and then expand to the generic public.

Some studies have already proved that physiological metrics such as slow wave sleep patterns and HRV will be improved via psychedelic therapies of Field Trip, sources confirmed. The potential collaboration between the two companies is to better understand the connection between physiology and mental wellbeing.

As per credible sources, WHOOP was recently valued at USD 1.2 billion after receiving over USD 100 million in a Series E funding round. At present, the company's bands are being used in a COVID-19 vaccine trials and have also been used on the LPGA tour to track the health of sports players.

Source Credits- https://www.globenewswire.com/news-release/2020/11/19/2130016/0/en/Field-Trip-Health-Ltd-and-WHOOP-announce-partnership-to-measure-effect-of-psychedelic-therapies-on-physiology-and-mental-health.html

 

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Spotify to allow access to all creators in its video podcast platform

Spotify to allow access to all creators in its video podcast platform

By Nikita Chaurasia

Audio streaming giant Spotify has announced the launch of its video podcast feature, which will be provided by its self-publishing podcast division, Anchor. According to sources, the feature will initially be offered on a rolling basis where interes...

U.K.’s competition regulator might look into the music streaming space

U.K.’s competition regulator might look into the music streaming space

By Nikita Chaurasia

The Competition and Markets Authority of the U.K. has revealed plans to launch a probe targeting the country’s music streaming market to ascertain if it is sufficiently consumer-centric and competitive. The announcement came after a U.K. parli...

India’s vaccination drive slows down as dose gap holds back output

India’s vaccination drive slows down as dose gap holds back output

By Nikita Chaurasia

India’s vaccination efforts have reportedly slowed down despite stockpiling vaccines as authorities are maintaining a more than usual gap between two shots. This is a part of the strategy to boost vaccine coverage in the country. The domestic ...